Dragonfly Therapeutics Appoints World Leader in NK Therapeutics as Chief Scientific Officer

Dr. Wagtmann, Ph.D, a globally recognized scientist with 20+ years of biotech and pharma industry experience joins Dragonfly's team to accelerate development of its novel Natural Killer cell-based immunotherapies.CAMBRIDGE, Massachussets, June 26, 2017 /PRNewswire/ -- Dragonfly...